Skip to main content
Erschienen in: Supportive Care in Cancer 9/2014

01.09.2014 | Original Article

Are orange lollies effective in preventing nausea and vomiting related to dimethyl sulfoxide? A multicenter randomized trial

verfasst von: Silvia Gonella, Paola Berchialla, Benedetto Bruno, Paola Di Giulio

Erschienen in: Supportive Care in Cancer | Ausgabe 9/2014

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Nausea and vomiting (NV) related to DMSO affect patients undergoing auto-SCT despite antiemetic measures. Orange flavoring may reduce gastrointestinal symptoms.

Methods

A multicenter, randomized, three-arm, open-label trial in four Italian large bone marrow transplant centers was conducted to assess the effectiveness of orange aroma in preventing NV related to DMSO. Patients were randomized to orange ice lollies, non-citrus ice lollies, and routine treatment (deep breaths) during reinfusion. Data on NV were collected up to 5 days after infusion; 69/98 patients were randomized: 23 to orange, 21 to non-citrus ice lollies, and 25 to routine treatment.

Results

Although 48 h after transplantation no differences were observed in controlled nausea (Numerical Rating Scale (NRS) 0–100, ≤25) or vomiting, significantly fewer patients had no episodes of vomiting, no antiemetic rescue therapy, and no nausea (NRS <5) in the deep breath vs lollies groups (P = 0.017). The intensity of nausea over time differed significantly between ice lollies vs routine care (P = 0.001) groups, but not between the orange and non-citrus groups (P = 0.428).

Conclusion

The vasoconstrictive action of ice may prevent NV related to DMSO in the acute phase and reduce the need for rescue antiemetic therapy. Ice lollies offer a simple, noninvasive, and economic means for relieving nausea and vomiting related to this preservative.
Literatur
4.
Zurück zum Zitat Horacek JM, Jebavy L, Jakl M, Zak P, Mericka P, Maly J (2009) Cardiovascular changes associated with infusion of hematopoietic cell grafts in oncohematological patients—impact of cryopreservation with dimethylsulfoxide. Exp Oncol 31:121–122PubMed Horacek JM, Jebavy L, Jakl M, Zak P, Mericka P, Maly J (2009) Cardiovascular changes associated with infusion of hematopoietic cell grafts in oncohematological patients—impact of cryopreservation with dimethylsulfoxide. Exp Oncol 31:121–122PubMed
5.
Zurück zum Zitat Prior D, Mitchell A, Nebauer M, Smith M (2000) Oncology nurses’ experience of dimethyl sulfoxide odor. Cancer Nurs 23:134–140PubMedCrossRef Prior D, Mitchell A, Nebauer M, Smith M (2000) Oncology nurses’ experience of dimethyl sulfoxide odor. Cancer Nurs 23:134–140PubMedCrossRef
7.
Zurück zum Zitat Cox MA, Kastrup J, Hrubisko M (2012) Historical perspectives and the future of adverse reactions associated with haemopoietic stem cell cryopreserved with dimethyl sulfoxide. Cell Tissue Bank 13:203–215. doi:10.1007/s10561-011-9248-2 PubMedCrossRef Cox MA, Kastrup J, Hrubisko M (2012) Historical perspectives and the future of adverse reactions associated with haemopoietic stem cell cryopreserved with dimethyl sulfoxide. Cell Tissue Bank 13:203–215. doi:10.​1007/​s10561-011-9248-2 PubMedCrossRef
11.
Zurück zum Zitat Ndao DH, Ladas EJ, Cheng B, Sands SA, Snyder KT, Garvin JH Jr et al (2012) Inhalation aromatherapy in children and adolescents undergoing stem cell infusion: results of a placebo-controlled double-blind trial. Psycho-Oncology 21:247–254. doi:10.1002/pon.1898 PubMedCrossRef Ndao DH, Ladas EJ, Cheng B, Sands SA, Snyder KT, Garvin JH Jr et al (2012) Inhalation aromatherapy in children and adolescents undergoing stem cell infusion: results of a placebo-controlled double-blind trial. Psycho-Oncology 21:247–254. doi:10.​1002/​pon.​1898 PubMedCrossRef
12.
Zurück zum Zitat Lopez-Jiménez J, Martin-Ballesteros E, Sureda A, Uralburo C, Lorenzo I, Del Campo R et al (2006) Chemotherapy-induced nausea and vomiting in acute leukemia and stem cell transplant patients: result of a multi-center observational study. Haematologica 91:84–91PubMed Lopez-Jiménez J, Martin-Ballesteros E, Sureda A, Uralburo C, Lorenzo I, Del Campo R et al (2006) Chemotherapy-induced nausea and vomiting in acute leukemia and stem cell transplant patients: result of a multi-center observational study. Haematologica 91:84–91PubMed
15.
Zurück zum Zitat Aungst JL, Heyward PM, Puche AC, Karnup SV, Hayar A, Szabo G et al (2003) Centre-surround inhibition among olfactory bulb glomeruli. Nature 426:623–629. doi:10.1038/nature02185 Aungst JL, Heyward PM, Puche AC, Karnup SV, Hayar A, Szabo G et al (2003) Centre-surround inhibition among olfactory bulb glomeruli. Nature 426:623–629. doi:10.​1038/​nature02185
20.
Zurück zum Zitat Hesketh PJ (1999) Defining the emetogenicity of cancer chemotherapy regimens: relevance to clinical practice. Oncologist 4:191–196PubMed Hesketh PJ (1999) Defining the emetogenicity of cancer chemotherapy regimens: relevance to clinical practice. Oncologist 4:191–196PubMed
21.
Zurück zum Zitat Harrell FE (2001) Regression modeling strategies with applications to linear model, logistic regression and survival analysis. Springer, New York Harrell FE (2001) Regression modeling strategies with applications to linear model, logistic regression and survival analysis. Springer, New York
24.
Zurück zum Zitat Sonis S, Elting L, Keefe D, Peterson DE, Schubert M, Hauer-Jensen M et al (2004) Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology and consequences for patients. Cancer 100(Suppl 9):1995–2025. doi:10.1002/cncr.20162 PubMedCrossRef Sonis S, Elting L, Keefe D, Peterson DE, Schubert M, Hauer-Jensen M et al (2004) Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology and consequences for patients. Cancer 100(Suppl 9):1995–2025. doi:10.​1002/​cncr.​20162 PubMedCrossRef
25.
Zurück zum Zitat Vokurka S, Bystricka E, Koza V, Scudlova J, Pavlicova V, Valentova D et al (2006) Higher incidence of chemotherapy induced oral mucositis in females: a supplement of multivariate analysis to a randomized multicentre study. Support Care Cancer 14:974–976. doi:10.1007/s00520-006-0031-z PubMedCrossRef Vokurka S, Bystricka E, Koza V, Scudlova J, Pavlicova V, Valentova D et al (2006) Higher incidence of chemotherapy induced oral mucositis in females: a supplement of multivariate analysis to a randomized multicentre study. Support Care Cancer 14:974–976. doi:10.​1007/​s00520-006-0031-z PubMedCrossRef
26.
Zurück zum Zitat Grazziutti ML, Dong L, Miceli MH, Krishna SG, Kiwan E, Syed N et al (2006) Oral mucositis in myeloma patients undergoing melphalan-based autologous stem cell transplantation: incidence, risk factors and a severity predictive model. Bone Marrow Transplant 38:501–506. doi:10.1038/sj.bmt.1705471 PubMedCrossRef Grazziutti ML, Dong L, Miceli MH, Krishna SG, Kiwan E, Syed N et al (2006) Oral mucositis in myeloma patients undergoing melphalan-based autologous stem cell transplantation: incidence, risk factors and a severity predictive model. Bone Marrow Transplant 38:501–506. doi:10.​1038/​sj.​bmt.​1705471 PubMedCrossRef
27.
Zurück zum Zitat Costa LJ, Micallef IN, Inwards DJ, Johnston PB, Porrata LF, Litzow MR et al (2008) Effect of the dose per body weight of conditioning chemotherapy on severity of mucositis and risk of relapse after autologous haematopoietic stem cell transplantation in relapsed diffuse large B cell lymphoma. BJH 143:268–273. doi:10.1111/j.1365-2141.2008.07342.x PubMedCrossRef Costa LJ, Micallef IN, Inwards DJ, Johnston PB, Porrata LF, Litzow MR et al (2008) Effect of the dose per body weight of conditioning chemotherapy on severity of mucositis and risk of relapse after autologous haematopoietic stem cell transplantation in relapsed diffuse large B cell lymphoma. BJH 143:268–273. doi:10.​1111/​j.​1365-2141.​2008.​07342.​x PubMedCrossRef
Metadaten
Titel
Are orange lollies effective in preventing nausea and vomiting related to dimethyl sulfoxide? A multicenter randomized trial
verfasst von
Silvia Gonella
Paola Berchialla
Benedetto Bruno
Paola Di Giulio
Publikationsdatum
01.09.2014
Verlag
Springer Berlin Heidelberg
Erschienen in
Supportive Care in Cancer / Ausgabe 9/2014
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-014-2227-y

Weitere Artikel der Ausgabe 9/2014

Supportive Care in Cancer 9/2014 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.